Literature DB >> 10566276

[Sepsis syndrome and bone marrow granulomatosis after intravesical instillation of BCG].

E Andrès1, C Kuhnert, A E Perrin, G Averous, A Ruellan, B Goichot, J L Schlienger.   

Abstract

BACKGROUND: BCG therapy is an effective treatment for superficial bladder carcinoma. Exceptionally, systemic disorders including hypersensitivity reactions or infections may occur. CASE REPORT: A 70-year-old man developed septicemia with bone marrow granulomatosis with a favorable course after intravesicle administration of bacillus Calmette-Guérin for bladder carcinoma. DISCUSSION: High grade fever, septicemia, hepatitis or pulmonary granulomatosis as well as bone marrow involvement are reported in less than 1% of all cases of BCG therapy. The pathogenic mechanisms are complex. Anti-tuberculous drugs are generally given.

Entities:  

Mesh:

Year:  1999        PMID: 10566276

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  Fever of unknown origin and pancytopenia caused by culture-proven delayed onset disseminated bacillus Calmette-Guerin (BCG) infection after intravesical instillation.

Authors:  Pedro Dammert; Ziad Boujaoude; William Rafferty; Jonathan Kass
Journal:  BMJ Case Rep       Date:  2013-04-09

2.  Systemic granulomatous reaction secondary to treatment of bladder cancer with bacillus calmette-guerin.

Authors:  Caterina Giovanna Valentini; Valentina Bozzoli; Anna Rita Larici; Luigi Maria Larocca; Giovanni Delogu; Giuseppe Leone; Livio Pagano
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-06-18       Impact factor: 2.576

Review 3.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.